GILD Update....Good Investment or Good Company...
Interestingly, GILD is both a good investment, a good trade and a good company, and not just a good company.
Given the really tiny divergence in my indicators (RSI), a break above the red line is looking possible. Try an RSI(14)..same thing.
A TINY Divergence in PVT indicator and volume clues:
Weak selling interest expressed in volume and price pattern today. A little messy because of the gap in Feb, 3 2015;
hence, the tiny divergence, which would have been bigger.
Oh, and last month an insider of this stock Director Olsen Per Wold, bought 10,000 shares of GILD, at $99.92 each per share. A total investment of $999,150.
It looks promising. I like today's candle. I purchased GILD shares already, and I am debating on whether to add more on Monday or buy the TQQQ index just in case this trade, and hopefully, semi-investment, doesn't work. Maybe it will help the biotech industry have an incentive to continue its trend; it has been in a range for some time (that things are still looking good).
Given the really tiny divergence in my indicators (RSI), a break above the red line is looking possible. Try an RSI(14)..same thing.
A TINY Divergence in PVT indicator and volume clues:
Weak selling interest expressed in volume and price pattern today. A little messy because of the gap in Feb, 3 2015;
hence, the tiny divergence, which would have been bigger.
Oh, and last month an insider of this stock Director Olsen Per Wold, bought 10,000 shares of GILD, at $99.92 each per share. A total investment of $999,150.
It looks promising. I like today's candle. I purchased GILD shares already, and I am debating on whether to add more on Monday or buy the TQQQ index just in case this trade, and hopefully, semi-investment, doesn't work. Maybe it will help the biotech industry have an incentive to continue its trend; it has been in a range for some time (that things are still looking good).
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.